- Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvantLi, Gen*; Yu, Meixing; Ke, Qiong; Sun, Jing; Peng, Yanwen; Xiong, Chuanfeng; Monteiro, Olivia; Zhao, Jincun*; Xiang, Andy*Signal Transduction and Targeted Therapy, 2023, 8(1): 213.
- Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccineZhao, Hui; Zhang, Na-Na; Hannawi, Suad; Zhu, Ai-Ru; Xiong, Xiao-Chuan; Huang, Yi-Jiao; Yu, Dan-Dan; Chen, Can-Jie; Dai, Jun; Abuquta, Alaa; Ying, Bo*; Zhao, Jin-Cun*; Qin, Cheng-Feng*Cell Discovery, 2024, 10(1): 7.
- Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, ChinaGuo, Jun; Zha, Lei; Zeng, Kai; Shao, Mingyu; Chen, Dan; Wang, Bing; Zhou, Yun; Yang, Gang; Zhang, Xue; Zou, Xia; Zhang, Yan; Kang, Yan*Chinese Medical Journal, 2023, 136(23): 2892-2894.
期刊论文
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
8被引15阅读
